Affinity-Asset-Advisors

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "NUVL",
  "AXSM",
  "EWTX",
  "TRVI",
  "CNTA",
  "ALKS",
  "INSM",
  "NAMS",
  "MDGL",
  "ALNY",
  "ABVX",
  "OLMA",
  "CATX",
  "MIRM",
  "THRD",
  "TVTX",
  "TRML",
  "NRIX",
  "MLYS",
  "KYMR",
  "ADGM",
  "AKBA",
  "ALLK",
  "AVTX",
  "AVR",
  "ESTA",
  "GERN",
  "GALT",
  "SYRE",
  "APGE",
  "AUTL",
  "NBIX",
  null,
  "LXEO",
  "MNPR",
  null,
  "NXTC",
  "NKTX",
  "OVID",
  "OKUR",
  "PRQR",
  "QTTB",
  "RPTX",
  "STRO",
  null,
  null,
  "RZLT",
  "EXEL",
  "TEVA",
  "IBRX",
  "ZURA",
  null,
  "SPY",
  null,
  null,
  "AMGN",
  null,
  null,
  null,
  "PTGX",
  "MBX",
  null,
  "SLNO",
  "ACLX",
  "QURE",
  "OMER",
  "ETNB",
  "WVE",
  "ROIV",
  null,
  "CNTX",
  "ERAS",
  "INZY",
  "VRNA",
  "VKTX",
  "VRDN",
  "XENE",
  "ORKA",
  "VERA",
  "IMVT",
  "PCVX",
  null,
  "BDTX",
  "BBIO",
  "CMPX",
  "CORT",
  "CRNX",
  "CGEM",
  "IWM",
  "MGTX"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-14
Total Holdings: 91
Total Value: 976714470
Accession Number: 0001999371-25-006074
Form Type: 13F-HR
CIK: affinity-asset-advisors
Manager Name: Affinity-Asset-Advisors

Data Enrichment

86% identified

78 identified13 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

91 positions • $976.7M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 5

Sort by:

ESTABLISHMENT LABS HOLDINGS INC.

ESTA|G31249108

Shares:280.0K

Value:$11.4M

% of Portfolio:1.2% ($11.4M/$976.7M)

INSMED Inc

INSM|457669307

Shares:140.0K

Value:$10.7M

% of Portfolio:1.1% ($10.7M/$976.7M)

BridgeBio Pharma, Inc.

BBIO|10806X102

Shares:300.0K

Value:$10.4M

% of Portfolio:1.1% ($10.4M/$976.7M)

Nurix Therapeutics, Inc.

NRIX|67080M103

Shares:810.7K

Value:$9.6M

% of Portfolio:1.0% ($9.6M/$976.7M)

Protagonist Therapeutics, Inc

PTGX|74366E102

Shares:172.5K

Value:$8.3M

% of Portfolio:0.9% ($8.3M/$976.7M)

CORCEPT THERAPEUTICS INC

CORT|218352102

Shares:70.0K

Value:$8.0M

% of Portfolio:0.8% ($8.0M/$976.7M)

Trevi Therapeutics, Inc.

TRVI|89532M101

Shares:1.3M

Value:$7.9M

% of Portfolio:0.8% ($7.9M/$976.7M)

Spyre Therapeutics, Inc.

SYRE|00773J202

Shares:481.7K

Value:$7.8M

% of Portfolio:0.8% ($7.8M/$976.7M)

Immunovant, Inc.

IMVT|45258J102

Shares:430.0K

Value:$7.3M

% of Portfolio:0.8% ($7.3M/$976.7M)

89422GAA5

Shares:—

Value:$7.0M

% of Portfolio:0.7% ($7.0M/$976.7M)

Vera Therapeutics, Inc.

VERA|92337R101

Shares:265.0K

Value:$6.4M

% of Portfolio:0.7% ($6.4M/$976.7M)

Oruka Therapeutics, Inc.

ORKA|687604108

Shares:545.4K

Value:$5.6M

% of Portfolio:0.6% ($5.6M/$976.7M)

NEUROCRINE BIOSCIENCES INC

NBIX|64125C109

Shares:50.0K

Value:$5.5M

% of Portfolio:0.6% ($5.5M/$976.7M)

Avalo Therapeutics, Inc.

AVTX|05338F306

Shares:657.2K

Value:$5.3M

% of Portfolio:0.5% ($5.3M/$976.7M)

Viridian Therapeutics, Inc.\DE

VRDN|92790C104

Shares:390.0K

Value:$5.3M

% of Portfolio:0.5% ($5.3M/$976.7M)

Lexeo Therapeutics, Inc.

LXEO|52886X107

Shares:1.5M

Value:$5.1M

% of Portfolio:0.5% ($5.1M/$976.7M)

Crinetics Pharmaceuticals, Inc.

CRNX|22663K107

Shares:152.3K

Value:$5.1M

% of Portfolio:0.5% ($5.1M/$976.7M)

EXELIXIS, INC.

EXEL|30161Q104

Shares:135.0K

Value:$5.0M

% of Portfolio:0.5% ($5.0M/$976.7M)

Rezolute, Inc.

RZLT|76200L309

Shares:1.7M

Value:$4.9M

% of Portfolio:0.5% ($4.9M/$976.7M)

Perspective Therapeutics, Inc.

CATX|46489V302

Shares:2.2M

Value:$4.7M

% of Portfolio:0.5% ($4.7M/$976.7M)

Instrument	Shares		Other Manager	Value	% of Portfolio
ESTABLISHMENT LABS HOLDINGS INC.(ESTAcusipG31249108)	280.0K	QoQ +0.19% (-555) YoY +460.00% (+230.0K)	All Managers (Combined)	$11.4M	1.2% ($11.4M/$976.7M)	QoQ -11.25% (-$1.4M) YoY +348.93% (+$8.9M)
INSMED Inc(INSMcusip457669307)	140.0K	QoQ +180.00% (+90.0K) YoY NEW(+140.0K)	All Managers (Combined)	$10.7M	1.1% ($10.7M/$976.7M)	QoQ +209.40% (+$7.2M) YoY NEW(+$10.7M)
BridgeBio Pharma, Inc.(BBIOcusip10806X102)	300.0K	QoQ +50.00% (+100.0K) YoY +500.00% (+250.0K)	All Managers (Combined)	$10.4M	1.1% ($10.4M/$976.7M)	QoQ +88.97% (+$4.9M) YoY +570.82% (+$8.8M)
Nurix Therapeutics, Inc.(NRIXcusip67080M103)	810.7K	QoQ -13.76% (-129.4K) YoY +0.05% (-416)	All Managers (Combined)	$9.6M	1.0% ($9.6M/$976.7M)	QoQ -45.62% (-$8.1M) YoY -19.14% (-$2.3M)
Protagonist Therapeutics, Inc(PTGXcusip74366E102)	172.5K	QoQ +32.69% (+42.5K) YoY +72.50% (+72.5K)	All Managers (Combined)	$8.3M	0.9% ($8.3M/$976.7M)	QoQ +66.24% (+$3.3M) YoY +188.35% (+$5.4M)
CORCEPT THERAPEUTICS INC(CORTcusip218352102)	70.0K	QoQ NEW(+70.0K) YoY NEW(+70.0K)	All Managers (Combined)	$8.0M	0.8% ($8.0M/$976.7M)	QoQ NEW(+$8.0M) YoY NEW(+$8.0M)
Trevi Therapeutics, Inc.(TRVIcusip89532M101)	1.3M	QoQ NEW(+1.3M) YoY NEW(+1.3M)	All Managers (Combined)	$7.9M	0.8% ($7.9M/$976.7M)	QoQ NEW(+$7.9M) YoY NEW(+$7.9M)
Spyre Therapeutics, Inc.(SYREcusip00773J202)	481.7K	QoQ -41.56% (-342.6K) YoY +17.48% (-71.7K)	All Managers (Combined)	$7.8M	0.8% ($7.8M/$976.7M)	QoQ -59.50% (-$11.4M) YoY -50.02% (-$7.8M)
Immunovant, Inc.(IMVTcusip45258J102)	430.0K	QoQ +330.00% (+330.0K) YoY +197.78% (+285.6K)	All Managers (Combined)	$7.3M	0.8% ($7.3M/$976.7M)	QoQ +196.67% (+$4.9M) YoY +57.50% (+$2.7M)
(cusip89422GAA5)✕	—	QoQ - YoY NEW	All Managers (Combined)	$7.0M	0.7% ($7.0M/$976.7M)	QoQ +21.74% (+$1.2M) YoY NEW(+$7.0M)
Vera Therapeutics, Inc.(VERAcusip92337R101)	265.0K	QoQ -37.64% (-160.0K) YoY -43.61% (-205.0K)	All Managers (Combined)	$6.4M	0.7% ($6.4M/$976.7M)	QoQ -64.58% (-$11.6M) YoY -68.59% (-$13.9M)
Oruka Therapeutics, Inc.(ORKAcusip687604108)	545.4K	QoQ +47.91% (-176.7K) YoY NEW(+545.4K)	All Managers (Combined)	$5.6M	0.6% ($5.6M/$976.7M)	QoQ -21.73% (-$1.6M) YoY NEW(+$5.6M)
NEUROCRINE BIOSCIENCES INC(NBIXcusip64125C109)	50.0K	QoQ NEW(+50.0K) YoY NEW(+50.0K)	All Managers (Combined)	$5.5M	0.6% ($5.5M/$976.7M)	QoQ NEW(+$5.5M) YoY NEW(+$5.5M)
Avalo Therapeutics, Inc.(AVTXcusip05338F306)	657.2K	QoQ +19.31% (+106.4K) YoY +6471.54% (+647.2K)	All Managers (Combined)	$5.3M	0.5% ($5.3M/$976.7M)	QoQ +28.63% (+$1.2M) YoY +2320.13% (+$5.0M)
Viridian Therapeutics, Inc.\DE(VRDNcusip92790C104)	390.0K	QoQ +144.33% (+230.4K) YoY NEW(+390.0K)	All Managers (Combined)	$5.3M	0.5% ($5.3M/$976.7M)	QoQ +71.81% (+$2.2M) YoY NEW(+$5.3M)
Lexeo Therapeutics, Inc.(LXEOcusip52886X107)	1.5M	QoQ NEW(+1.5M) YoY NEW(+1.5M)	All Managers (Combined)	$5.1M	0.5% ($5.1M/$976.7M)	QoQ NEW(+$5.1M) YoY NEW(+$5.1M)
Crinetics Pharmaceuticals, Inc.(CRNXcusip22663K107)	152.3K	QoQ -66.90% (-307.7K) YoY -67.60% (-317.7K)	All Managers (Combined)	$5.1M	0.5% ($5.1M/$976.7M)	QoQ -78.28% (-$18.4M) YoY -76.78% (-$16.9M)
EXELIXIS, INC.(EXELcusip30161Q104)	135.0K	QoQ NEW(+135.0K) YoY NEW(+135.0K)	All Managers (Combined)	$5.0M	0.5% ($5.0M/$976.7M)	QoQ NEW(+$5.0M) YoY NEW(+$5.0M)
Rezolute, Inc.(RZLTcusip76200L309)	1.7M	QoQ +7.93% (-125.0K) YoY +6.25% (+100.0K)	All Managers (Combined)	$4.9M	0.5% ($4.9M/$976.7M)	QoQ -36.11% (-$2.8M) YoY +20.83% (+$850.0K)
Perspective Therapeutics, Inc.(CATXcusip46489V302)	2.2M	QoQ +71.09% (+924.2K) YoY NEW(+2.2M)	All Managers (Combined)	$4.7M	0.5% ($4.7M/$976.7M)	QoQ +14.24% (+$590.5K) YoY NEW(+$4.7M)